Gara Jalqabaatti › Kansarii Hafuu Seli Xiqqaa › Washington › Seattle
Qorannoo klinikaalii Kansarii Hafuu Seli Xiqqaa Seattle, WA keessatti
Qorannoo 10 Kansarii Hafuu Seli Xiqqaa f Seattle fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Fred Hutchinson Cancer Research Center, Seattle
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Washington Fred Hutchinson, Seattle
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
Namoota walitti qabaa jiraSadarkaa 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Namoota walitti qabaa jiraSadarkaa 3
- Swedish Medical Center, Seattle
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Namoota walitti qabaa jiraSadarkaa 1/2
- Avenzo Therapeutics Recruiting Site, Seattle
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Fred Hutch Cancer Research, Seattle
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Namoota walitti qabaa jiraSadarkaa 1/2
- Fred Hutch Cancer Center, Seattle
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Swedish Cancer Institute, Seattle
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Namoota walitti qabaa jiraSadarkaa 1
- Swedish Cancer Institute, Seattle
Qorannoo Kansarii Hafuu Seli Xiqqaa magaalota biroo keessatti
- Houston, TXQorannoo 26
- Arlington, VAQorannoo 23
- Boston, MAQorannoo 21
- New York City, NYQorannoo 21
- Nashville, TNQorannoo 20
- Los Angeles, CAQorannoo 20
- Orlando, FLQorannoo 15
- Dallas, TXQorannoo 13
- St. Louis, MOQorannoo 13
- Cleveland, OHQorannoo 13
- Detroit, MIQorannoo 12
- Chicago, ILQorannoo 12
Qorannoo biroo Seattle keessatti
- Kansara Qara'a Non-Small CellQorannoo 53
- Saree (Gosoota Hunda)Qorannoo 49
- Kansarii ProstateQorannoo 42
- Leukemia Myeloidii HamaaQorannoo 40
- Saree OljooQorannoo 39
- Kansara MetastatikiiQorannoo 39
- Kansarii ColorectalQorannoo 34
- Dhibee QaraQorannoo 33
- Kansarii OvariiQorannoo 30
- Myeloma Baay’eeQorannoo 22
- Myelodysplastic SyndromesQorannoo 21
- Leukemia Lymphoblasticii HamaaQorannoo 21
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.